Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07349680Phase 3Completed
A Phase 3 trial of bupivacaine, methylprednisolone in herpes zoster (HZ), postherpetic neuralgia (PHN), sponsored by Assiut University. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07349680.